Hidoc Dr launches India's first KOL Factory to bridge gap between drug firms and reputed doctors

Hidoc Dr, India's most comprehensive platform for doctors' networking, has launched a one-stop solution known as Key Opinion Leaders (KOL) Factory to bridge the gap between pharmaceutical businesses and India's top doctors in the wake of the Covid-19

NTAGI to examine data from CMC Vellore's study on mixing and matching of Covid-19 vaccines

The Covid-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review data from a study conducted by Christian Medical College (CMC), Vellore on mixing and matching of Covid-19 vaccines-in a meeting to be held

Alembic Pharma gets USFDA permission for $797 mn generic BP drug

Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administration to launch a generic form of blood pressure tablet Opsumit.Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administr

Unique deal gives desi pharma companies share of cancer drug's $8 billion US pie

A blockbuster cancer drug in the US with annual sales of over $8 billion may just become a win-win for all stakeholders - the innovator, domestic generic companies as well as patients. This is in the wake of a 'unique' patent settlement where US majo

Flexible manufacturing to Transform the Pharma Ecosystem

The times are changing, so are the methods in which the pharmaceutical sector used to function.

Govt announces norms for strengthening of pharma industry scheme

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers on Friday released guidelines for 'Strengthening of Pharmaceutical Industry (SPI)' scheme that is seen to address rising demand in terms of support required to existing Pharma clust

Pharma stocks surge on positive cues from Nifty healthcare, Cipla up 6%

Taking positive cues from Nifty healthcare index, domestic pharma stocks outperformed all other sectoral stocks on Friday, with shares of Cipla leading the pack.

Bharat Biotech says supply chains are not impacted by Russia-Ukraine conflict

Indian vaccine maker Bharat Biotech said on Friday the Russia-Ukraine conflict had not impacted the company's supply chains so far. Unlike several Western companies including McDonald's, Microsoft, Coca-Cola and Starbucks that have stopped sales or

Why Real World Evidence is Beneficial for Pharma Companies

As the healthcare industry across the globe has started focusing increasingly on outcomes, pharma companies are looking to sources beyond Randomized Clinical Trials (RCTs) to measure and demonstrate the value they bring.

Dr. Reddy's Pharma Company plans to continue its Business in Russia

Pharmaceutical major Dr. Reddy's Laboratories Ltd said it is focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days. No Indian company has publicly withdrawn from

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.